Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer’s disease mouse model
Wioleta M. Zelek(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Bart De Strooper(VIB-KU Leuven Center for Brain & Disease Research), Ryan J. Bevan(UK Dementia Research Institute), Maarten Dewilde(Research & Diagnostic Antibodies (United States)), Jacqui Nimmo(UK Dementia Research Institute)
Cited by 18
Related Papers
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
|Alzheimer s Research & Therapy|2010|562
Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis
|Nature|1998|517
Alteration of the microRNA network during the progression of Alzheimer's disease
|EMBO Molecular Medicine|2013|476